Reinisch W - Search Results

1

Effects of Mirikizumab on Histologic Resolution of Crohn's Disease in a Randomized Controlled Phase 2 Trial.

Magro F, Protic M, De Hertogh G, Chan LS, Pollack P, Jairath V, Carlier H, Hon E, Feagan BG, Harpaz N, Pai R, Reinisch W. Magro F, et al. Among authors: reinisch w. Clin Gastroenterol Hepatol. 2023 Nov 20:S1542-3565(23)00948-5. doi: 10.1016/j.cgh.2023.11.010. Online ahead of print. Clin Gastroenterol Hepatol. 2023. PMID: 37993033 Free article.

2

Delayed Ustekinumab Responders in Ulcerative Colitis Have Greater Inflammatory Burden but Similar Outcomes as Early Responders.

Wong ECL, Dulai PS, Marshall JK, Jairath V, Reinisch W, Narula N. Wong ECL, et al. Among authors: reinisch w. Clin Gastroenterol Hepatol. 2023 Dec;21(13):3387-3396.e1. doi: 10.1016/j.cgh.2023.06.011. Epub 2023 Jun 29. Clin Gastroenterol Hepatol. 2023. PMID: 37391059

3

Washout Periods in Inflammatory Bowel Disease Trials: A Systematic Literature Review and Proposed Solutions.

Wils P, Jairath V, Sands BE, Reinisch W, Danese S, Peyrin-Biroulet L. Wils P, et al. Among authors: reinisch w. Clin Gastroenterol Hepatol. 2024 Apr;22(4):896-898.e13. doi: 10.1016/j.cgh.2023.09.011. Epub 2023 Sep 22. Clin Gastroenterol Hepatol. 2024. PMID: 37743039

4

Predicting Endoscopic Improvement in Ulcerative Colitis Using the Ulcerative Colitis Severity Index.

Wong ECL, Dulai PS, Marshall JK, Jairath V, Reinisch W, Narula N. Wong ECL, et al. Among authors: reinisch w. Inflamm Bowel Dis. 2024 Mar 1;30(3):370-381. doi: 10.1093/ibd/izad074. Inflamm Bowel Dis. 2024. PMID: 37116893

5

Mirikizumab as Induction and Maintenance Therapy for Ulcerative Colitis.

D'Haens G, Dubinsky M, Kobayashi T, Irving PM, Howaldt S, Pokrotnieks J, Krueger K, Laskowski J, Li X, Lissoos T, Milata J, Morris N, Arora V, Milch C, Sandborn W, Sands BE; LUCENT Study Group. D'Haens G, et al. N Engl J Med. 2023 Jun 29;388(26):2444-2455. doi: 10.1056/NEJMoa2207940. N Engl J Med. 2023. PMID: 37379135 Clinical Trial.

6

Comparative Efficacy of Infliximab Versus Tofacitinib for Inducing Remission in Biologic Naive Ulcerative Colitis: A Propensity Matched Study.

Wong ECL, Merat S, Monaco C, Dulai PS, Jairath V, Marshall JK, Reinisch W, Narula N. Wong ECL, et al. Among authors: reinisch w. Dig Dis Sci. 2023 Jun;68(6):2635-2646. doi: 10.1007/s10620-023-07956-8. Epub 2023 Apr 29. Dig Dis Sci. 2023. PMID: 37119375

7

Matching-adjusted Indirect Comparisons vs Propensity Score Matching with Individual Patient-level Data to Estimate Treatment Efficacy.

Wong ECL, Dulai PS, Marshall JK, Jairath V, Reinisch W, Narula N. Wong ECL, et al. Among authors: reinisch w. Inflamm Bowel Dis. 2024 Feb 1;30(2):311-313. doi: 10.1093/ibd/izad077. Inflamm Bowel Dis. 2024. PMID: 37186256 No abstract available.

8

Mirikizumab-Induced Transcriptome Changes in Ulcerative Colitis Patient Biopsies at Week 12 Are Maintained Through Week 52.

Johnson T, Steere B, Zhang P, Zang Y, Higgs R, Milch C, Reinisch W, Panés J, Huang K, D'Haens G, Krishnan V. Johnson T, et al. Among authors: reinisch w. Clin Transl Gastroenterol. 2023 Nov 1;14(11):e00630. doi: 10.14309/ctg.0000000000000630. Clin Transl Gastroenterol. 2023. PMID: 37594044 Free PMC article.

9

Modified-Release Phosphatidylcholine (LT-02) for Ulcerative Colitis: Two Double-Blind, Randomized, Placebo-Controlled Trials.

Dignass A, Stremmel W, Horyński M, Poyda O, Armerding P, Fellermann K, Langhorst J, Kuehbacher T, Uebel P, Stein J, Novacek G, Avalueva E, Oliinyk O, Hasselblatt P, Dorofeyev A, Heinemann H, Mueller R, Greinwald R, Reinisch W; International PROTECT-1/2 Study Groups. Dignass A, et al. Among authors: reinisch w. Clin Gastroenterol Hepatol. 2024 Apr;22(4):810-820.e7. doi: 10.1016/j.cgh.2023.09.031. Epub 2023 Oct 6. Clin Gastroenterol Hepatol. 2024. PMID: 37806372 Free article. Clinical Trial.

10

Impact of Concomitant 5-Aminosalicylic Acid Therapy on Vedolizumab Efficacy and Safety in Inflammatory Bowel Disease: Post Hoc Analyses of Clinical Trial Data.

Ungaro RC, Kadali H, Zhang W, Adsul S, Reinisch W. Ungaro RC, et al. Among authors: reinisch w. J Crohns Colitis. 2023 Dec 30;17(12):1949-1961. doi: 10.1093/ecco-jcc/jjad113. J Crohns Colitis. 2023. PMID: 37492976 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

440 results

Search Page